About the AGILE Clinical Trial Platform On 13 February 2021, the Department of Health and Social Care announced a new initiative under which the UK government is providing millions of pounds of additional funding to expand the new AGILE clinical trial platform. The funding has been awarded by the Medical Research Council (MRC) and co-funded though the National Institute for Health Research (NIHR). This new platform will allow for global innovators to progress cutting-edge treatments for COVID-19 through all 3 clinical trial phases in the UK, further protecting our supply chain. This in turn will attract the brightest of researchers and manufacturers from around the world to trial their medicines here in Britain.